Radiation dosimetry of <sup>15</sup>O-water based on dynamic large axial field of view PET
Listen to this summary
The authors aimed to provide more accurate estimates of radiation dosimetry for <sup>15</sup>O-water using dynamic large axial field of view (LAFOV) PET scanning, as previous estimates were based on limited data. Their findings revealed a sex-averaged effective dose coefficient of 0.62 μSv/MBq, leading to a significantly lower effective dose of approximately 0.25 mSv for typical cardiac scans, compared to earlier estimates. This suggests that LAFOV PET can enhance dosimetry accuracy for this radiotracer.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.
More from Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
View all →Jul 18, 2026 · Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
Incremental prognostic value of the hemodynamic gain index in patients undergoing exercise stress myocardial perfusion imaging
Jul 11, 2026 · Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
Transient Ischemic Dilation with <sup>18</sup>F-flurpiridaz PET: Establishing Thresholds for a Novel Radiotracer
Jul 3, 2026 · Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
Clinical Application and Research Advances of PET Molecular Imaging in Immune Checkpoint Inhibitor-Associated Myocarditis
Jul 2, 2026 · Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
Immuno-PET in Cardiovascular Disease: Advances, Challenges, and Opportunities
Jun 30, 2026 · Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
Normal Values for <sup>13</sup>N-Ammonia PET-derived Metrics in Heart Transplant Patients
Jun 9, 2026 · Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
PROGNOSTIC IMPACT OF MYOCARDIAL FLOW RESERVE ASSESSED BY CZT-SPECT
More in Nuclear Medicine
View all →Aug 6, 2026 · Lancet (London, England)
[<sup>177</sup>Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial
Aug 5, 2026 · The New England journal of medicine
Syncope
Jul 31, 2026 · Lancet (London, England)
Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial
Jul 30, 2026 · Lancet (London, England)
Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial
Jul 30, 2026 · Lancet (London, England)
Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial
Jul 29, 2026 · Lancet (London, England)
Deramiocel heart-derived cellular therapy in advanced Duchenne muscular dystrophy (HOPE-3): a phase 3, randomised, double-blind, placebo-controlled trial
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR
Stay current without falling behind
33,000+ journals. 3-minute audio summaries. Free for 14 days.
